MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
Conditions: Schizophrenia and Related Disorders; Mitochondrial Alteration; Cognitive Impairment Interventions: Drug: MitoQ; Drug: Placebo Sponsors: Mclean Hospital; Yale University; University of Lausanne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Investigating the Role of Diazepam on Brain Function and Chemistry in Psychosis Risk
Conditions: Prodromal Schizophrenia Interventions: Drug: Diazepam 5 Mg Oral Tablet; Drug: Ascorbic Acid 50 Mg Oral Tablet Sponsors: King ' s College London; Wellcome Trust; The Royal Society Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Stratifying Psychoses for Personalized REpetitive TMS in Persistent NEgative Symptoms Alleviation
Conditions: Schizophrenia; Persistent Negative Symptoms; Progressive Periodic Catatonia; Aviation; Apathy Interventions: Procedure: Personalized rTMS Sponsors: University Hospital, Strasbourg, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient
Conditions: Severe Mental Disorder; Schizophrenia; Personality Disorders; Mood Disorders; Bipolar Disorder; Depressive Disorder; Anxiety Disorders; Psychotic Episode; Schizoaffective Disorder Sponsors: Sheba Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate LB-102 in the Treatment of Adult Patients With Acute Schizophrenia
Conditions: Schizophrenia Interventions: Drug: LB-102 Sponsors: LB Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
Conditions: Schizophrenia Interventions: Drug: LB-102 Sponsors: LB Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia
Conditions: Schizophrenia and Related Disorders; Medication Adherence; Mental Health Issue; Gamification Interventions: Combination Product: Healing Town: Embedded Narrative in Interactive Game Design Sponsors: Zhu Dian Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia
Conditions: Catatonia; Schizophrenia; Schizo Affective Disorder; Bipolar Affective Disorder Interventions: Diagnostic Test: rTMS; Other: Placebo Sponsors: Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Lumateperone Study
Conditions: Schizophrenia; Schizo Affective Disorder Interventions: Drug: Lumateperone; Drug: Placebo Sponsors: Xiaoduo Fan; Intra-Cellular Therapies, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Characterizing Response to Antipsychotics in Schizophrenia
Conditions: Schizophrenia; Schizoaffective Disorder Interventions: Drug: Olanzapine; Drug: Clozapine Sponsors: The Royal Ottawa Mental Health Centre; The Royal ' s Institute of Mental Health Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
TMS for Inhibition Enhancement in Schizophrenia
Conditions: Schizophrenia Interventions: Device: repetitive transcranial magnetic stimulation Sponsors: University of Maryland, Baltimore; National Institute of Mental Health (NIMH) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Cognitive Effects of tDCS and tRNS in Schizophrenia
Conditions: Schizophrenia; Cognitive Impairment Interventions: Device: transcranial direct current stimulation (tDCS); Device: transcranial random noise stimulation (tRNS) Sponsors: The National Brain Mapping Laboratory (NBML); Leibniz-Institut f ür Arbeitsforschung; Payame Noor University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Auditory Control Enhancement (ACE) in Schizophrenia
Conditions: Auditory Hallucinations Interventions: Device: Transcranial Direct Current Stimulation (tDCS); Behavioral: Auditory Cognitive Control Training (ACCT) Sponsors: Brian A Coffman, PhD; National Institute of Mental Health (NIMH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Intermittent Theta Burst Stimulation of the Precuneus
Conditions: Schizophrenia Interventions: Procedure: stimulation device Sponsors: GCS Ramsay Sant é pour l ' Enseignement et la Recherche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia
Conditions: Schizophrenia Spectrum Disorders Interventions: Other: Oxytocin; Other: Placebo Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
